Reckitt Loses Reconsideration Bid In Mucinex Antitrust Row
Reckitt Benckiser Inc.'s bid to escape an antitrust and contract breach lawsuit filed by URL Pharma Inc. over a right to sell generic Mucinex has again fallen short, with a Pennsylvania...To view the full article, register now.
Already a subscriber? Click here to view full article